MétaCan
Menu
← Back to cohort
Record W4411107136 · doi:10.3389/fimmu.2025.1573365

Elevated Siglec-7 expression correlates with adverse clinicopathological, immunological, and therapeutic response signatures in breast cancer patients

2025· article· en· W4411107136 on OpenAlexaboutno aff
Hamza Benthami, Basma Zohair, Ibtissam Rezouki, Oumayma Naji, Kenza Miyara, Simohamed Ennachit, Mohamed Elkarroumi, H. Aschawa, Abdallah Badou

Bibliographic record

VenueFrontiers in Immunology · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicGlycosylation and Glycoproteins Research
Canadian institutionsnot available
Fundersnot available
KeywordsSIGLECMedicineBreast cancerAdverse effectCancerImmunologyComplete responseCancer researchOncologyImmune systemInternal medicineChemotherapy

Abstract

fetched live from OpenAlex

Introduction: Breast cancer is a highly heterogeneous malignancy, characterized by an intricate, hypersialylated tumor microenvironment that actively inhibits immune functions. Although immune checkpoint inhibitors have marked clinical advantages in various tumor types, their efficacy in Triple-Negative Breast Cancer (TNBC) and Human Epidermal Growth Factor Receptor 2 positive (HER2+) patients remains limited. Siglec-7 has emerged as a novel and promising candidate for advancing cancer immunotherapy. Methods: Herein, we explored the potential role of Siglec-7, a key inhibitory glycoimmune checkpoint, in human breast tumor microenvironment in a cohort of 45 Moroccan patients. Subsequently, data were corroborated using large-scale data from independent cohorts of American and British-Canadian patients, the TCGA and METABRIC. Results: We report that Siglec-7 transcripts were significantly upregulated in breast tumor tissues compared to matched adjacent non-invaded tissues. Furthermore, higher Siglec-7 expression correlated with poor clinicopathological features, including negative Estrogen Receptor (ER) and Progesterone Receptor (PR) status, advanced tumor grades, and unfavorable patient prognosis. Siglec-7 overexpression was linked to gene expression patterns, known to promote breast tumor progression through pathways involved in proliferation, invasion, and immune escape. Notably, high Siglec-7 expression was associated with increased infiltration of immunosuppressive cells and T-cells with an exhausted phenotype. Interestingly, a positive correlation between siglec-7 and A2AR, another emerging and potent inhibitory checkpoint, was revealed, along with the co-upregulation of other inhibitory immune checkpoint genes; and this was associated with signatures of impaired immune effector functions. Finally, our data also pinpointed an interesting role of high Siglec-7 expression in predicting resistance to conventional therapies, including chemotherapy, endocrine treatments, and immunotherapy. Discussion: These findings strongly suggest a central role for Siglec-7 as a promising therapeutic target and prognostic biomarker for human breast cancer, warranting further investigation into its clinical potential.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.006
GPT teacher head0.264
Teacher spread0.257 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueFrontiers in Immunology→Same topicGlycosylation and Glycoproteins Research→French-language works237,207→